Related Experiment Video

Updated: Jul 23, 2026

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
09:57

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

[Middle molecules and tuberculosis activity in children and adolescents at the sanatorium stage of treatment]

M E Lozovskaia, O I Korol', V P Sokurov

    Problemy Tuberkuleza
    |January 1, 1996
    PubMed

    Insights

    Medium-weight molecules (MWM) can help detect tuberculosis activity in children and adolescents. Lowering MWM levels during treatment indicates therapeutic effectiveness for tuberculosis patients.

    Area of Science:

    • Biochemistry
    • Immunology
    • Pediatrics

    Context:

    • Tuberculosis (TB) diagnosis in pediatric patients can be challenging.
    • Assessing treatment efficacy requires reliable biomarkers.
    • Medium-weight molecules (MWM) have emerged as potential indicators in various inflammatory conditions.

    Purpose:

    • To investigate the diagnostic and prognostic value of MWM in pediatric tuberculosis.
    • To evaluate MWM levels in relation to different TB manifestations.
    • To assess the utility of MWM as a marker for treatment response in children and adolescents with TB.

    Summary:

    • This study measured plasma MWM levels in 67 children and adolescents (11-17 years) with diverse forms of tuberculosis.
    • Elevated MWM levels were observed in patients with tuberculous exudative pleuritis and infiltrative pulmonary tuberculosis.
    • A significant reduction in mean MWM levels was noted in 20 patients during treatment, suggesting therapeutic efficacy.

    Impact:

    • MWM measurement can aid in detecting subclinical tuberculosis activity during convalescent care.
    • MWM serves as a valuable criterion for evaluating the effectiveness of tuberculosis therapies in pediatric populations.
    • This research supports the integration of MWM assessment into routine monitoring protocols for pediatric TB patients.

    More Related Videos

    System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis09:57

    System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

    Published on: April 5, 2017

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    Related Concept Videos

    Pulmonary Tuberculosis I01:29

    Pulmonary Tuberculosis I

    Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
    Causative Organism
    The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
    Mode of...
    Pulmonary Tuberculosis II01:28

    Pulmonary Tuberculosis II

    Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
    Here is a detailed explanation of its pathophysiology:
    Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
    Pulmonary Tuberculosis III01:31

    Pulmonary Tuberculosis III

    Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
    The first classification is based on the development of the disease, and it includes the following categories:
    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Tuberculosis01:23

    Tuberculosis

    Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...